Clinical trial
A Single-center, Retrospective Study on the Efficacy and Safety of Conversion Therapy for Patients With Initially Unresectable Hepatocellular Carcinoma
NCT06365034 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-center, Retrospective Study on the Efficacy and Safety of Conversion Therapy for Patients With Initially Unresectable Hepatocellular Carcinoma
- Lead sponsor
- Qianfoshan Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 1, 2024
- Completion date
- January 31, 2025
- Enrollment
- 92 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.